Posted by Toi Williams on Mar 5th, 2019
The U.S. Food and Drug Administration has approved a new
drug to treat depression that is derived from an old and widely used
anesthetic, ketamine. The new nasal spray treatment, called esketamine, was developed
by Janssen Pharmaceuticals...
More of this article »